OBINUTUZUMAB

OBINUTUZUMAB was reported 16929 times

OBINUTUZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DISSEMINATED ENTEROVIRAL INFECTION 8 0.4444
1 FOLLICULAR LYMPHOMA REFRACTORY 27 0.4154
2 FOLLICULAR LYMPHOMA RECURRENT 32 0.4000
3 FOLLICULAR LYMPHOMA 185 0.2102
4 MANTLE CELL LYMPHOMA REFRACTORY 13 0.1970
5 AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT 14 0.1573
6 SPLEEN ATROPHY 9 0.1525
7 FOLLICULAR LYMPHOMA STAGE IV 6 0.1463
8 APOPTOTIC COLONOPATHY 11 0.1325
9 MENINGITIS ENTEROVIRAL 12 0.1290
10 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 84 0.1205
11 BACILLUS BACTERAEMIA 13 0.1193
12 LYMPHOMA TRANSFORMATION 40 0.1111
13 B-LYMPHOCYTE ABNORMALITIES 15 0.1049
14 RETICULOCYTOPENIA 13 0.0890
15 ENCEPHALITIS ENTEROVIRAL 9 0.0796
16 REFRACTORY CANCER 17 0.0794
17 LYMPHOCYTIC LYMPHOMA 6 0.0723
18 LEUKAEMIC INFILTRATION 10 0.0714
19 B-CELL LYMPHOMA RECURRENT 37 0.0681
20 CHRONIC LYMPHOCYTIC LEUKAEMIA REFRACTORY 6 0.0638
21 LISTERIA SEPSIS 16 0.0606
22 CEREBRAL ASPERGILLOSIS 36 0.0585
23 ORGANIC BRAIN SYNDROME 11 0.0585
24 TUMOUR FLARE 39 0.0571
25 ASPERGILLUS INFECTION 367 0.0559
26 HYPERTENSIVE CARDIOMYOPATHY 15 0.0540
27 ERYTHROSIS 7 0.0464
28 ALLOGENIC STEM CELL TRANSPLANTATION 7 0.0443
29 POST-ACUTE COVID-19 SYNDROME 53 0.0428
30 CYTOPENIA 479 0.0391
31 TUMOUR LYSIS SYNDROME 344 0.0391
32 COR PULMONALE CHRONIC 7 0.0372
33 HYPOGAMMAGLOBULINAEMIA 244 0.0371
34 CYTOKINE INCREASED 5 0.0370
35 SICCA SYNDROME 7 0.0363
36 CELL-MEDIATED IMMUNE DEFICIENCY 5 0.0357
37 BACILLUS INFECTION 21 0.0332
38 CYTOMEGALOVIRUS CHORIORETINITIS 59 0.0302
39 CORONAVIRUS PNEUMONIA 5 0.0299
40 HUMORAL IMMUNE DEFECT 11 0.0296
41 BORRELIA INFECTION 9 0.0286
42 CYTOMEGALOVIRUS ENTEROCOLITIS 22 0.0286
43 RETROPERITONEAL LYMPHADENOPATHY 15 0.0285
44 MEASLES 15 0.0278
45 MANTLE CELL LYMPHOMA RECURRENT 12 0.0276
46 CYTOKINE RELEASE SYNDROME 547 0.0272
47 COVID-19 PNEUMONIA 317 0.0268
48 BONE MARROW NECROSIS 6 0.0256
49 NEUTROPENIC INFECTION 24 0.0251
50 BLADDER HYPERTROPHY 11 0.0249
51 BLOOD IMMUNOGLOBULIN G DECREASED 61 0.0246
52 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 54 0.0245
53 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 23 0.0243
54 HYDROURETER 9 0.0237
55 CHRONIC LYMPHOCYTIC LEUKAEMIA 111 0.0234
56 PNEUMONIA HAEMOPHILUS 11 0.0226
57 AMERICAN TRYPANOSOMIASIS 6 0.0222
58 LYMPHOCYTIC LEUKAEMIA 9 0.0221
59 LUPUS NEPHRITIS 41 0.0219
60 OSTEOMYELITIS BACTERIAL 6 0.0219
61 BLOOD IMMUNOGLOBULIN A DECREASED 14 0.0215
62 FEBRILE INFECTION 23 0.0195
63 DIFFUSE LARGE B-CELL LYMPHOMA 150 0.0194
64 GASTRIC VARICES 9 0.0191
65 MANTLE CELL LYMPHOMA 29 0.0190
66 MINIMAL RESIDUAL DISEASE 9 0.0186
67 IMMUNODEFICIENCY COMMON VARIABLE 9 0.0184
68 ACUTE HEPATITIS B 6 0.0181
69 ENDOCARDITIS BACTERIAL 14 0.0178
70 CYTOMEGALOVIRUS HEPATITIS 6 0.0169
71 IDIOPATHIC INTERSTITIAL PNEUMONIA 6 0.0169
72 ABDOMINAL LYMPHADENOPATHY 14 0.0161
73 OBLITERATIVE BRONCHIOLITIS 21 0.0160
74 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 94 0.0159
75 DISSEMINATED CRYPTOCOCCOSIS 12 0.0159
76 FEBRILE NEUTROPENIA 1049 0.0158
77 BRAIN ABSCESS 40 0.0158
78 LYMPH GLAND INFECTION 7 0.0155
79 LYMPHOCYTOSIS 33 0.0153
80 LYMPHOCYTE COUNT INCREASED 50 0.0153
81 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 5 0.0152
82 MYELOSUPPRESSION 547 0.0152
83 ENTEROCOLITIS INFECTIOUS 14 0.0152
84 ENTEROVIRUS INFECTION 13 0.0150
85 BLOOD LACTATE DEHYDROGENASE DECREASED 5 0.0150
86 ECTHYMA 6 0.0150
87 ABDOMINAL NEOPLASM 13 0.0146
88 APLASIA PURE RED CELL 49 0.0142
89 DEPENDENCE ON OXYGEN THERAPY 7 0.0142
90 CYTOMEGALOVIRUS ENTERITIS 5 0.0140
91 URGE INCONTINENCE 12 0.0138
92 ENCEPHALITIS CYTOMEGALOVIRUS 6 0.0137
93 MALIGNANT TRANSFORMATION 6 0.0134
94 INFUSION RELATED REACTION 882 0.0133
95 CYTOMEGALOVIRUS INFECTION REACTIVATION 58 0.0131
96 OPPORTUNISTIC INFECTION 24 0.0130
97 BODY MASS INDEX DECREASED 6 0.0130
98 ORGANISING PNEUMONIA 64 0.0129
99 BRONCHOPULMONARY ASPERGILLOSIS 99 0.0128
100 LYMPHOCYTE COUNT DECREASED 225 0.0127
101 VACCINATION FAILURE 21 0.0126
102 SUPERINFECTION BACTERIAL 10 0.0126
103 PNEUMOCYSTIS JIROVECII INFECTION 15 0.0126
104 SARS-COV-2 ANTIBODY TEST NEGATIVE 6 0.0125
105 MENINGITIS LISTERIA 6 0.0118
106 LISTERIOSIS 13 0.0118
107 B-LYMPHOCYTE COUNT DECREASED 16 0.0117
108 SERUM SICKNESS 32 0.0115
109 CYTOMEGALOVIRUS TEST POSITIVE 20 0.0112
110 DEVICE RELATED THROMBOSIS 11 0.0112
111 CHYLOTHORAX 8 0.0111
112 URETHRITIS 6 0.0111
113 INTERCEPTED PRODUCT STORAGE ERROR 39 0.0109
114 CORONAVIRUS INFECTION 72 0.0109
115 CAMPYLOBACTER INFECTION 9 0.0108
116 VITH NERVE PARALYSIS 12 0.0105
117 CYTOMEGALOVIRUS INFECTION 174 0.0105
118 NEUTROPENIA 1407 0.0103
119 VENA CAVA THROMBOSIS 17 0.0102
120 HEPATITIS E 16 0.0101
121 HEPATOSPLENOMEGALY 26 0.0101
122 HISTOPLASMOSIS DISSEMINATED 16 0.0101
123 JC VIRUS INFECTION 16 0.0100
124 B-CELL LYMPHOMA 34 0.0100
125 EPIDIDYMITIS 11 0.0095
126 NECROTISING RETINITIS 6 0.0094
127 PROCALCITONIN INCREASED 11 0.0094
128 BLOOD LACTATE DEHYDROGENASE INCREASED 147 0.0093
129 HYPERPYREXIA 39 0.0092
130 SECONDARY IMMUNODEFICIENCY 11 0.0091
131 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 74 0.0090
132 CD4 LYMPHOCYTES DECREASED 19 0.0089
133 PNEUMOTHORAX SPONTANEOUS 6 0.0088
134 HEPATITIS B REACTIVATION 28 0.0088
135 NEUTROPENIC SEPSIS 63 0.0088
136 CUTANEOUS SYMPTOM 6 0.0088
137 SOFT TISSUE INFECTION 16 0.0087
138 IMMUNOGLOBULINS DECREASED 12 0.0087
139 THROMBOCYTOPENIA 963 0.0086
140 CAMPYLOBACTER GASTROENTERITIS 5 0.0084
141 URINARY TRACT INFECTION BACTERIAL 21 0.0083
142 NEUROENDOCRINE CARCINOMA OF THE SKIN 8 0.0082
143 DISEASE PROGRESSION 961 0.0081
144 NEUTROPHIL COUNT DECREASED 330 0.0081
145 LYMPHOMA 125 0.0081
146 ORAL FUNGAL INFECTION 22 0.0080
147 LYMPHOCYTE COUNT ABNORMAL 9 0.0080
148 HAEMATOTOXICITY 75 0.0079
149 VARICELLA ZOSTER VIRUS INFECTION 16 0.0077
150 PERTUSSIS 8 0.0077
151 SPLENOMEGALY 89 0.0076
152 GRANULOCYTE COUNT DECREASED 14 0.0075
153 HYPERPHOSPHATAEMIA 16 0.0074
154 STRONGYLOIDIASIS 12 0.0074
155 ANAL ULCER 6 0.0073
156 PNEUMOCYSTIS JIROVECII PNEUMONIA 73 0.0073
157 CENTRAL NERVOUS SYSTEM LYMPHOMA 10 0.0073
158 CYTOMEGALOVIRUS VIRAEMIA 32 0.0072
159 INFECTED BITE 6 0.0071
160 BACTERIAL SEPSIS 23 0.0071
161 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 15 0.0070
162 BLOOD IMMUNOGLOBULIN M DECREASED 7 0.0070
163 LYMPHADENOPATHY 245 0.0069
164 PULMONARY SEPSIS 10 0.0069
165 BACTERIAL DISEASE CARRIER 5 0.0069
166 SQUAMOUS CELL CARCINOMA 64 0.0068
167 HYPERLEUKOCYTOSIS 6 0.0068
168 PNEUMONIA CYTOMEGALOVIRAL 13 0.0067
169 TEMPERATURE INTOLERANCE 69 0.0067
170 ENCEPHALITIS VIRAL 8 0.0066
171 TOXOPLASMOSIS 7 0.0065
172 SMALL INTESTINAL PERFORATION 12 0.0064
173 NEUTROPHIL COUNT ABNORMAL 18 0.0064
174 FEBRILE BONE MARROW APLASIA 27 0.0063
175 AGRANULOCYTOSIS 117 0.0063
176 INTERCEPTED MEDICATION ERROR 29 0.0063
177 COVID-19 1094 0.0062
178 BLOOD PHOSPHORUS INCREASED 17 0.0062
179 ATRIAL FIBRILLATION 606 0.0062
180 BLOOD FIBRINOGEN DECREASED 7 0.0061
181 PNEUMONIA FUNGAL 24 0.0061
182 MUCOSAL DISORDER 6 0.0060
183 IMMUNE THROMBOCYTOPENIA 27 0.0059
184 VARICELLA 14 0.0059
185 MONOCYTE COUNT INCREASED 21 0.0058
186 AXILLARY MASS 6 0.0058
187 CLOSTRIDIUM COLITIS 7 0.0058
188 METASTASES TO MENINGES 13 0.0057
189 BASAL CELL CARCINOMA 89 0.0057
190 END STAGE RENAL DISEASE 104 0.0057
191 CYTOMEGALOVIRUS COLITIS 13 0.0056
192 SQUAMOUS CELL CARCINOMA OF SKIN 34 0.0056
193 MYELODYSPLASTIC SYNDROME 81 0.0056
194 CANDIDA SEPSIS 5 0.0056
195 INVESTIGATION ABNORMAL 8 0.0056
196 ESCHERICHIA BACTERAEMIA 13 0.0055
197 ADJUSTMENT DISORDER 7 0.0054
198 ADENOCARCINOMA GASTRIC 5 0.0054
199 ADVERSE FOOD REACTION 5 0.0054
200 MYOCARDIAL INJURY 6 0.0053
201 HEPATITIS B 32 0.0053
202 HYPERSENSITIVITY PNEUMONITIS 6 0.0053
203 ERYSIPELAS 26 0.0052
204 PSEUDOMONAL SEPSIS 9 0.0051
205 PNEUMONIA BACTERIAL 47 0.0051
206 MEGACOLON 8 0.0051
207 OSTEOSCLEROSIS 8 0.0051
208 SECOND PRIMARY MALIGNANCY 42 0.0050
209 PNEUMONIA INFLUENZAL 6 0.0050
210 LYMPHADENITIS 12 0.0050
211 INJECTION RELATED REACTION 8 0.0048
212 BLOOD CREATININE DECREASED 15 0.0048
213 PANCYTOPENIA 262 0.0047
214 PNEUMONITIS 127 0.0047
215 PLATELET TRANSFUSION 6 0.0047
216 BACTERAEMIA 55 0.0046
217 HEPATIC CYTOLYSIS 59 0.0046
218 TRANSITIONAL CELL CARCINOMA 6 0.0046
219 HYPERURICAEMIA 19 0.0046
220 THERAPY PARTIAL RESPONDER 72 0.0046
221 HYPERAEMIA 9 0.0046
222 ACUTE MYELOID LEUKAEMIA 70 0.0045
223 ESCHERICHIA URINARY TRACT INFECTION 19 0.0045
224 ADENOCARCINOMA 10 0.0045
225 CHILLS 523 0.0045
226 STAPHYLOCOCCAL SEPSIS 22 0.0045
227 ATYPICAL PNEUMONIA 13 0.0043
228 INFECTION 625 0.0043
229 DERMATITIS EXFOLIATIVE GENERALISED 15 0.0043
230 LYMPHOPENIA 61 0.0043
231 OESOPHAGEAL CANDIDIASIS 17 0.0043
232 EAR SWELLING 9 0.0042
233 PLATELET COUNT DECREASED 450 0.0042
234 HYPOPROTEINAEMIA 8 0.0042
235 NEOPLASM 48 0.0042
236 RHINOVIRUS INFECTION 16 0.0041
237 ABDOMINAL MASS 11 0.0041
238 ENDOCARDITIS 21 0.0041
239 PNEUMONIA VIRAL 13 0.0041
240 CHOLANGIOCARCINOMA 6 0.0040
241 VASCULAR PSEUDOANEURYSM 7 0.0040
242 LUNG ADENOCARCINOMA 12 0.0040
243 MIXED LIVER INJURY 12 0.0040
244 SMALL CELL LUNG CANCER 6 0.0040
245 NEPHROTIC SYNDROME 27 0.0039
246 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 7 0.0039
247 QUADRIPLEGIA 8 0.0039
248 NEUTROPENIC COLITIS 8 0.0039
249 CLOSTRIDIUM DIFFICILE COLITIS 41 0.0039
250 RESPIRATORY TRACT INFECTION VIRAL 9 0.0039
251 ANAEMIA 737 0.0039
252 HERPES SIMPLEX 25 0.0038
253 HEPATITIS TOXIC 10 0.0038
254 IMMUNODEFICIENCY 57 0.0038
255 VENOUS THROMBOSIS 15 0.0038
256 URINARY TRACT OBSTRUCTION 9 0.0038
257 GASTROINTESTINAL STROMAL TUMOUR 10 0.0038
258 HYPERTRANSAMINASAEMIA 26 0.0037
259 ADENOCARCINOMA OF COLON 7 0.0037
260 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 28 0.0037
261 BRONCHITIS CHRONIC 9 0.0037
262 HAEMORRHAGE 385 0.0037
263 TACHYPNOEA 50 0.0037
264 OTITIS MEDIA 12 0.0036
265 SYSTEMIC CANDIDA 9 0.0036
266 HYPERCALCAEMIA 44 0.0036
267 LEUKAEMIA RECURRENT 6 0.0035
268 ATYPICAL MYCOBACTERIAL INFECTION 5 0.0035
269 NEUTROPHIL COUNT INCREASED 36 0.0035
270 BLADDER NEOPLASM 6 0.0035
271 BLOOD DISORDER 28 0.0035
272 HYPOALBUMINAEMIA 27 0.0035
273 WHITE BLOOD CELL COUNT ABNORMAL 22 0.0034
274 METABOLIC DISORDER 20 0.0034
275 ANAPHYLACTOID REACTION 14 0.0034
276 CAPILLARY LEAK SYNDROME 7 0.0034
277 RED CELL DISTRIBUTION WIDTH INCREASED 14 0.0034
278 WHITE BLOOD CELL COUNT DECREASED 364 0.0034
279 BONE MARROW FAILURE 68 0.0033
280 HYDRONEPHROSIS 25 0.0033
281 GASTROINTESTINAL OBSTRUCTION 8 0.0033
282 RESPIRATORY TRACT INFECTION 86 0.0033
283 ATRIAL FLUTTER 26 0.0033
284 APLASTIC ANAEMIA 17 0.0033
285 PNEUMOPERITONEUM 6 0.0032
286 HYPOPHOSPHATAEMIA 24 0.0032
287 DRUG SPECIFIC ANTIBODY PRESENT 21 0.0032
288 ENCEPHALITIS 22 0.0032
289 NON-CARDIAC CHEST PAIN 10 0.0032
290 SKIN INFECTION 35 0.0031
291 ENTEROCOLITIS 18 0.0031
292 IMMUNE SYSTEM DISORDER 41 0.0031
293 PHYSICAL DECONDITIONING 8 0.0031
294 ESCHERICHIA SEPSIS 9 0.0031
295 HAEMORRHAGIC DIATHESIS 11 0.0031
296 SEPTIC SHOCK 134 0.0031
297 HYPOXIA 108 0.0031
298 CHOLANGITIS 19 0.0031
299 CHRONIC GRAFT VERSUS HOST DISEASE 11 0.0030
300 STAPHYLOCOCCAL BACTERAEMIA 13 0.0030
301 PYREXIA 1027 0.0030
302 LEUKOPENIA 148 0.0030
303 NO ADVERSE EVENT 536 0.0030
304 BLOOD URIC ACID INCREASED 17 0.0029
305 LUNG INFILTRATION 26 0.0029
306 AUTOIMMUNE HAEMOLYTIC ANAEMIA 10 0.0029
307 BENIGN PROSTATIC HYPERPLASIA 15 0.0029
308 CHOLECYSTITIS INFECTIVE 8 0.0029
309 ANAEMIA MACROCYTIC 6 0.0028
310 PLATELET DISORDER 7 0.0028
311 BLOOD ALBUMIN DECREASED 22 0.0028
312 HAEMOTHORAX 8 0.0028
313 ASPARTATE AMINOTRANSFERASE INCREASED 146 0.0027
314 MUSCLE HAEMORRHAGE 11 0.0027
315 ABDOMINAL INFECTION 7 0.0027
316 SEPSIS 305 0.0027
317 EPSTEIN-BARR VIRUS INFECTION 17 0.0027
318 MENOPAUSE 7 0.0027
319 MUCORMYCOSIS 7 0.0027
320 PSEUDOMEMBRANOUS COLITIS 6 0.0027
321 OXYGEN SATURATION DECREASED 151 0.0027
322 CLOSTRIDIAL INFECTION 9 0.0027
323 SUSPECTED OFF LABEL USE 12 0.0027
324 DISSEMINATED INTRAVASCULAR COAGULATION 37 0.0026
325 LICHENOID KERATOSIS 6 0.0026
326 INTERSTITIAL LUNG DISEASE 127 0.0026
327 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 10 0.0026
328 HAEMOLYSIS 20 0.0026
329 DRUG RESISTANCE 66 0.0026
330 BRONCHIOLITIS 9 0.0026
331 METASTATIC NEOPLASM 11 0.0025
332 COLITIS 95 0.0025
333 ANAL HAEMORRHAGE 7 0.0025
334 UROSEPSIS 23 0.0025
335 PNEUMONIA 805 0.0025
336 NECK MASS 7 0.0025
337 OXYGEN SATURATION ABNORMAL 7 0.0025
338 BACTERIAL INFECTION 46 0.0025
339 GRANULOCYTOPENIA 14 0.0025
340 RECURRENT CANCER 10 0.0024
341 MUCOSAL INFLAMMATION 64 0.0024
342 AMYLASE INCREASED 9 0.0024
343 TRANSAMINASES INCREASED 54 0.0024
344 VASCULAR DEVICE INFECTION 11 0.0024
345 SUPRAVENTRICULAR TACHYCARDIA 23 0.0024
346 HERPES ZOSTER 138 0.0024
347 MENINGITIS 16 0.0024
348 C-REACTIVE PROTEIN INCREASED 86 0.0024
349 NOCARDIOSIS 6 0.0023
350 PULMONARY TUBERCULOSIS 10 0.0023
351 MULTIPLE ORGAN DYSFUNCTION SYNDROME 66 0.0023
352 PLATELET COUNT ABNORMAL 14 0.0023
353 PYELONEPHRITIS 20 0.0023
354 ANAPHYLACTIC SHOCK 59 0.0023
355 PERONEAL NERVE PALSY 13 0.0023
356 OFF LABEL USE 1999 0.0023
357 LUNG OPACITY 6 0.0023
358 BRONCHOSPASM 32 0.0022
359 HAEMOLYTIC ANAEMIA 20 0.0022
360 BRONCHIECTASIS 15 0.0022
361 PERIPHERAL SENSORY NEUROPATHY 13 0.0022
362 HYPOKALAEMIA 101 0.0022
363 CHOLECYSTITIS 26 0.0022
364 ACUTE CORONARY SYNDROME 18 0.0022
365 INTENTIONAL PRODUCT USE ISSUE 190 0.0022
366 MALIGNANT MELANOMA 29 0.0022
367 RASH MACULO-PAPULAR 48 0.0022
368 HYPOMAGNESAEMIA 30 0.0022
369 WHITE BLOOD CELL COUNT INCREASED 82 0.0021
370 ALANINE AMINOTRANSFERASE INCREASED 131 0.0021
371 ACUTE RESPIRATORY FAILURE 41 0.0021
372 IMMUNE THROMBOCYTOPENIC PURPURA 6 0.0021
373 RESPIRATORY SYMPTOM 6 0.0021
374 HYPERTHERMIA 16 0.0021
375 APHTHOUS ULCER 16 0.0021
376 EMBOLISM 17 0.0020
377 CHEST DISCOMFORT 209 0.0020
378 IMMUNOSUPPRESSION 18 0.0020
379 LYMPHOEDEMA 14 0.0020
380 CAROTID ARTERY STENOSIS 7 0.0020
381 LUNG INFECTION 31 0.0020
382 MYELOFIBROSIS 6 0.0020
383 PLEURAL EFFUSION 120 0.0020
384 PULMONARY ALVEOLAR HAEMORRHAGE 11 0.0020
385 BODY TEMPERATURE INCREASED 40 0.0020
386 PERIPHERAL VENOUS DISEASE 8 0.0020
387 BLOOD PRESSURE DIASTOLIC INCREASED 9 0.0019
388 RESPIRATORY FAILURE 142 0.0019
389 GRAFT VERSUS HOST DISEASE 14 0.0019
390 EXTRAVASATION 8 0.0019
391 ANAPHYLACTIC REACTION 107 0.0019
392 INFUSION SITE EXTRAVASATION 12 0.0019
393 RESPIRATORY RATE INCREASED 17 0.0019
394 POISONING 24 0.0019
395 BLOOD PRESSURE DECREASED 126 0.0019
396 SARS-COV-2 TEST POSITIVE 25 0.0019
397 HEPATIC FUNCTION ABNORMAL 70 0.0019
398 NEOPLASM PROGRESSION 65 0.0019
399 THERAPY NON-RESPONDER 84 0.0019
400 ENTEROCOCCAL INFECTION 9 0.0019
401 HYPOTENSION 373 0.0019
402 HYPERKALAEMIA 64 0.0018
403 SUSPECTED COVID-19 6 0.0018
404 UPPER RESPIRATORY TRACT INFECTION 84 0.0018
405 VENTRICULAR TACHYCARDIA 30 0.0018
406 BLOOD BILIRUBIN INCREASED 49 0.0018
407 HYPERTENSIVE CRISIS 20 0.0018
408 HEPATOTOXICITY 40 0.0018
409 FULL BLOOD COUNT ABNORMAL 19 0.0018
410 NEOPLASM RECURRENCE 6 0.0018
411 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 9 0.0018
412 FACIAL PARALYSIS 15 0.0018
413 SINUS BRADYCARDIA 17 0.0018
414 PSEUDOMONAS INFECTION 15 0.0017
415 BLEPHARITIS 7 0.0017
416 HYPERBILIRUBINAEMIA 18 0.0017
417 THROMBOPHLEBITIS 6 0.0017
418 THROMBOTIC THROMBOCYTOPENIC PURPURA 6 0.0017
419 HEPATITIS ACUTE 11 0.0017
420 SINUS TACHYCARDIA 24 0.0017
421 FIBRIN D DIMER INCREASED 6 0.0017
422 ACUTE HEPATIC FAILURE 23 0.0017
423 ANAL ABSCESS 9 0.0017
424 HUMERUS FRACTURE 8 0.0017
425 VIRAL INFECTION 55 0.0017
426 CLOSTRIDIUM DIFFICILE INFECTION 36 0.0016
427 INCORRECT DRUG ADMINISTRATION RATE 7 0.0016
428 VITAMIN D DEFICIENCY 16 0.0016
429 FOLLICULITIS 17 0.0016
430 INTRACRANIAL PRESSURE INCREASED 9 0.0016
431 ANGIOPATHY 9 0.0016
432 LEUKOCYTOSIS 29 0.0016
433 BLOOD BLISTER 5 0.0016
434 PROTEIN TOTAL DECREASED 6 0.0016
435 CHOLECYSTITIS ACUTE 9 0.0016
436 POLYNEUROPATHY 19 0.0016
437 ABDOMINAL ABSCESS 7 0.0016
438 ACUTE RESPIRATORY DISTRESS SYNDROME 28 0.0016
439 LIPASE INCREASED 12 0.0016
440 URINARY TRACT DISORDER 7 0.0016
441 ATELECTASIS 15 0.0016
442 GLOMERULAR FILTRATION RATE DECREASED 19 0.0015
443 SUBDURAL HAEMATOMA 22 0.0015
444 ORAL INFECTION 6 0.0015
445 SKIN CANCER 33 0.0015
446 COLD SWEAT 27 0.0015
447 ILEUS 19 0.0015
448 MALNUTRITION 17 0.0015
449 SERUM FERRITIN INCREASED 8 0.0015
450 CARDIAC FAILURE ACUTE 10 0.0015
451 APPENDICITIS 14 0.0015
452 RHINITIS 12 0.0015
453 LOWER GASTROINTESTINAL HAEMORRHAGE 11 0.0015
454 HYPERGLYCAEMIA 54 0.0015
455 HAEMORRHAGE INTRACRANIAL 22 0.0015
456 PERICARDIAL EFFUSION 34 0.0015
457 WOUND INFECTION 16 0.0015
458 SUBCUTANEOUS ABSCESS 7 0.0015
459 ECCHYMOSIS 10 0.0015
460 GUILLAIN-BARRE SYNDROME 7 0.0014
461 GASTROENTERITIS 21 0.0014
462 HEART RATE ABNORMAL 8 0.0014
463 RED BLOOD CELL COUNT DECREASED 41 0.0014
464 ONYCHOMADESIS 6 0.0014
465 DEVICE RELATED INFECTION 22 0.0014
466 INTESTINAL PERFORATION 16 0.0014
467 BREATH SOUNDS ABNORMAL 7 0.0014
468 REBOUND EFFECT 16 0.0014
469 SYNCOPE 141 0.0014
470 HERPES VIRUS INFECTION 8 0.0014
471 SMALL INTESTINAL OBSTRUCTION 17 0.0014
472 RESPIRATORY SYNCYTIAL VIRUS INFECTION 12 0.0014
473 LEUKAEMIA 13 0.0014
474 BLOOD PHOSPHORUS DECREASED 5 0.0014
475 PARONYCHIA 6 0.0014
476 INITIAL INSOMNIA 14 0.0014
477 ASCITES 40 0.0014
478 MASS 19 0.0014
479 FLUSHING 138 0.0014
480 LIVER FUNCTION TEST INCREASED 29 0.0013
481 FUNGAL INFECTION 45 0.0013
482 PLEURISY 8 0.0013
483 PULMONARY EMBOLISM 128 0.0013
484 CARDIAC DISORDER 126 0.0013
485 CARDIOTOXICITY 12 0.0013
486 HEPATOCELLULAR INJURY 19 0.0013
487 URINARY TRACT INFECTION 228 0.0013
488 THROMBOTIC MICROANGIOPATHY 13 0.0013
489 CHRONIC SINUSITIS 5 0.0013
490 POLYARTHRITIS 7 0.0013
491 HEPATOMEGALY 13 0.0013
492 HYPOCALCAEMIA 25 0.0013
493 INFARCTION 9 0.0013
494 INGUINAL HERNIA 8 0.0013
495 HAEMATOCRIT DECREASED 26 0.0013
496 MYOCARDITIS 15 0.0013
497 FOOD POISONING 7 0.0013
498 AUTOIMMUNE HEPATITIS 9 0.0013
499 FULL BLOOD COUNT DECREASED 26 0.0013
500 ERYTHEMA MULTIFORME 12 0.0013
501 LIVER DISORDER 57 0.0013
502 SKIN REACTION 18 0.0013
503 DERMATITIS ALLERGIC 16 0.0013
504 BLEPHAROSPASM 8 0.0013
505 LIVER INJURY 31 0.0013
506 DISEASE RECURRENCE 60 0.0013
507 HAEMATURIA 43 0.0013
508 ENTERITIS 8 0.0012
509 PERICARDITIS 21 0.0012
510 PURPURA 11 0.0012
511 CENTRAL NERVOUS SYSTEM LESION 17 0.0012
512 DECREASED IMMUNE RESPONSIVENESS 12 0.0012
513 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 67 0.0012
514 ACUTE MYOCARDIAL INFARCTION 36 0.0012
515 INJECTION SITE EXTRAVASATION 15 0.0012
516 HYPERVOLAEMIA 6 0.0012
517 NIGHT SWEATS 39 0.0012
518 BLOOD CREATININE INCREASED 79 0.0012
519 COLON CANCER 18 0.0012
520 FLUID INTAKE REDUCED 6 0.0012
521 DERMATITIS EXFOLIATIVE 6 0.0012
522 TACHYCARDIA 106 0.0012
523 CELLULITIS 60 0.0012
524 ACUTE KIDNEY INJURY 182 0.0012
525 KLEBSIELLA INFECTION 6 0.0012
526 MOUTH ULCERATION 25 0.0012
527 TROPONIN INCREASED 9 0.0012
528 DRUG INTOLERANCE 114 0.0012
529 CEREBRAL ISCHAEMIA 6 0.0012
530 ATRIOVENTRICULAR BLOCK 9 0.0012
531 HAEMOGLOBIN DECREASED 119 0.0012
532 ILL-DEFINED DISORDER 70 0.0012
533 PETECHIAE 12 0.0011
534 CHOLESTASIS 22 0.0011
535 MYOCARDIAL ISCHAEMIA 13 0.0011
536 LARYNGEAL OEDEMA 7 0.0011
537 CONJUNCTIVITIS 21 0.0011
538 GAMMA-GLUTAMYLTRANSFERASE INCREASED 25 0.0011
539 CARDIAC FAILURE 90 0.0011
540 GASTROINTESTINAL INFECTION 10 0.0011
541 PRESCRIBED UNDERDOSE 22 0.0011
542 LUNG DISORDER 54 0.0011
543 BLOOD PRESSURE SYSTOLIC DECREASED 5 0.0011
544 HICCUPS 9 0.0011
545 ESCHERICHIA INFECTION 9 0.0011
546 MALIGNANT NEOPLASM PROGRESSION 112 0.0011
547 NEUROPATHY PERIPHERAL 104 0.0011
548 CHOKING SENSATION 6 0.0011
549 TASTE DISORDER 22 0.0011
550 SUBARACHNOID HAEMORRHAGE 11 0.0011
551 STREPTOCOCCAL INFECTION 6 0.0011
552 FEELING COLD 30 0.0011
553 ARRHYTHMIA 51 0.0011
554 PULMONARY MASS 16 0.0011
555 DRUG ERUPTION 19 0.0011
556 BLOOD TEST ABNORMAL 15 0.0011
557 TRANSFUSION 11 0.0010
558 DEEP VEIN THROMBOSIS 68 0.0010
559 STOMATITIS 63 0.0010
560 METASTASES TO LYMPH NODES 7 0.0010
561 HYPERSENSITIVITY 192 0.0010
562 EJECTION FRACTION DECREASED 16 0.0010
563 GROIN PAIN 9 0.0010
564 ONYCHOCLASIS 7 0.0010
565 ASPIRATION 11 0.0010
566 DERMATITIS 21 0.0010
567 HYPERHIDROSIS 129 0.0010
568 PROTEINURIA 19 0.0010
569 HYPERTENSION 211 0.0010
570 PULMONARY FIBROSIS 19 0.0010
571 BRONCHITIS 73 0.0010
572 ERUCTATION 19 0.0010
573 METASTASIS 7 0.0010
574 RETINAL DETACHMENT 9 0.0010
575 PHARYNGEAL OEDEMA 15 0.0010
576 DIVERTICULITIS 27 0.0010
577 CYSTITIS 31 0.0010
578 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 25 0.0010
579 SPINAL COMPRESSION FRACTURE 8 0.0010
580 BLOOD ALKALINE PHOSPHATASE INCREASED 24 0.0010
581 PERITONITIS 20 0.0010
582 BRADYCARDIA 51 0.0010
583 LABORATORY TEST ABNORMAL 28 0.0009
584 SKIN LESION 26 0.0009
585 CARDIOMYOPATHY 14 0.0009
586 DYSPNOEA 534 0.0009
587 HAEMOGLOBIN ABNORMAL 6 0.0009
588 ANAL FISSURE 5 0.0009
589 HEART RATE INCREASED 92 0.0009
590 AUTOIMMUNE DISORDER 9 0.0009
591 PALLOR 25 0.0009
592 ELECTROCARDIOGRAM QT PROLONGED 33 0.0009
593 PRODUCT PREPARATION ISSUE 6 0.0009
594 FEELING HOT 56 0.0009
595 HEPATIC ENZYME INCREASED 62 0.0009
596 RESPIRATORY DISTRESS 25 0.0009
597 HEPATITIS 23 0.0009
598 GOUT 16 0.0009
599 PHARYNGITIS 11 0.0009
600 COUGH 247 0.0009
601 ULCER 14 0.0009
602 DEAFNESS 23 0.0009
603 CARDIAC VALVE DISEASE 5 0.0009
604 ANGINA PECTORIS 25 0.0009
605 JOINT EFFUSION 6 0.0009
606 SHOCK 20 0.0009
607 HAEMATOMA 22 0.0008
608 INFLUENZA 94 0.0008
609 HEMIPLEGIA 7 0.0008
610 PNEUMONIA ASPIRATION 21 0.0008
611 SKIN DISORDER 28 0.0008
612 GASTROINTESTINAL DISORDER 75 0.0008
613 PULMONARY OEDEMA 37 0.0008
614 DIARRHOEA 533 0.0008
615 BODY TEMPERATURE DECREASED 8 0.0008
616 STEVENS-JOHNSON SYNDROME 18 0.0008
617 DIPLOPIA 21 0.0008
618 NEPHROPATHY TOXIC 9 0.0008
619 DRUG-INDUCED LIVER INJURY 25 0.0008
620 CARDIAC ARREST 65 0.0008
621 HYPOPHAGIA 20 0.0008
622 PRODUCT PREPARATION ERROR 16 0.0008
623 MUSCULOSKELETAL CHEST PAIN 12 0.0008
624 LOW DENSITY LIPOPROTEIN INCREASED 6 0.0008
625 OROPHARYNGEAL DISCOMFORT 7 0.0008
626 RASH 336 0.0008
627 HEART RATE DECREASED 27 0.0008
628 PULMONARY HAEMORRHAGE 6 0.0008
629 GENERAL PHYSICAL HEALTH DETERIORATION 88 0.0008
630 GASTRITIS 20 0.0008
631 PANCREATITIS ACUTE 17 0.0008
632 SUDDEN DEATH 8 0.0008
633 ABDOMINAL PAIN LOWER 19 0.0008
634 BONE PAIN 44 0.0008
635 RETCHING 16 0.0007
636 ATRIOVENTRICULAR BLOCK COMPLETE 5 0.0007
637 FLANK PAIN 7 0.0007
638 BLOOD SODIUM DECREASED 14 0.0007
639 ADRENAL INSUFFICIENCY 9 0.0007
640 MUSCLE DISORDER 6 0.0007
641 RENAL FAILURE 98 0.0007
642 ENCEPHALOPATHY 18 0.0007
643 GENERALISED OEDEMA 9 0.0007
644 PHOTOSENSITIVITY REACTION 12 0.0007
645 RENAL IMPAIRMENT 61 0.0007
646 ASTHENIA 271 0.0007
647 PEMPHIGUS 9 0.0007
648 BACK PAIN 167 0.0007
649 TREMOR 119 0.0007
650 VOMITING 336 0.0007
651 BLOOD CALCIUM DECREASED 8 0.0007
652 PSYCHOTIC DISORDER 21 0.0007
653 CANDIDA INFECTION 12 0.0007
654 PRODUCT STORAGE ERROR 62 0.0007
655 BLOOD PRESSURE ABNORMAL 14 0.0007
656 BRAIN FOG 11 0.0007
657 CYANOSIS 11 0.0007
658 MUSCLE TWITCHING 16 0.0007
659 TUBULOINTERSTITIAL NEPHRITIS 13 0.0007
660 HYPONATRAEMIA 39 0.0007
661 HYPOTHERMIA 7 0.0007
662 CHEST PAIN 128 0.0007
663 PLATELET COUNT INCREASED 9 0.0007
664 NAUSEA 545 0.0007
665 URINE OUTPUT DECREASED 6 0.0007
666 MUSCULOSKELETAL DISORDER 13 0.0007
667 SPINAL OSTEOARTHRITIS 6 0.0007
668 TOOTH INFECTION 9 0.0007
669 MELAENA 15 0.0007
670 OEDEMA PERIPHERAL 83 0.0007
671 EAR INFECTION 18 0.0007
672 ARTHROPOD BITE 5 0.0007
673 VENTRICULAR EXTRASYSTOLES 7 0.0007
674 RENAL INJURY 20 0.0007
675 PRODUCT PRESCRIBING ERROR 16 0.0007
676 MYOSITIS 6 0.0007
677 ANAL INCONTINENCE 6 0.0007
678 THROAT TIGHTNESS 18 0.0007
679 LOWER RESPIRATORY TRACT INFECTION 30 0.0007
680 BLOOD COUNT ABNORMAL 10 0.0007
681 UPPER GASTROINTESTINAL HAEMORRHAGE 11 0.0007
682 INCREASED TENDENCY TO BRUISE 6 0.0007
683 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 34 0.0007
684 INTERCEPTED PRODUCT PREPARATION ERROR 8 0.0006
685 HEMIPARESIS 11 0.0006
686 DEATH 557 0.0006
687 BLINDNESS UNILATERAL 9 0.0006
688 AFFECTIVE DISORDER 5 0.0006
689 RESPIRATORY DISORDER 19 0.0006
690 SINUSITIS 65 0.0006
691 ABDOMINAL PAIN 147 0.0006
692 BLOOD POTASSIUM DECREASED 19 0.0006
693 PNEUMOTHORAX 10 0.0006
694 VENTRICULAR FIBRILLATION 7 0.0006
695 HEPATIC FAILURE 19 0.0006
696 DEHYDRATION 84 0.0006
697 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 6 0.0006
698 NEUROTOXICITY 11 0.0006
699 TRANSIENT ISCHAEMIC ATTACK 21 0.0006
700 LOSS OF CONSCIOUSNESS 79 0.0006
701 WEIGHT DECREASED 172 0.0006
702 BLOOD PRESSURE SYSTOLIC INCREASED 12 0.0006
703 PHARYNGEAL SWELLING 6 0.0006
704 GASTROINTESTINAL HAEMORRHAGE 51 0.0006
705 ABNORMAL FAECES 5 0.0006
706 PRODUCT USE IN UNAPPROVED INDICATION 151 0.0006
707 OEDEMA 33 0.0006
708 NECK PAIN 34 0.0006
709 OSTEOMYELITIS 11 0.0006
710 HOSPICE CARE 6 0.0006
711 PULMONARY CONGESTION 8 0.0006
712 STAPHYLOCOCCAL INFECTION 20 0.0006
713 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 43 0.0006
714 ELECTROLYTE IMBALANCE 7 0.0006
715 BLOOD UREA INCREASED 10 0.0006
716 CONSTIPATION 130 0.0006
717 BLOOD PRESSURE INCREASED 91 0.0006
718 HEPATIC STEATOSIS 11 0.0006
719 OSTEOARTHRITIS 25 0.0006
720 PANCREATITIS 31 0.0006
721 ERYTHEMA 120 0.0006
722 BLOOD MAGNESIUM DECREASED 5 0.0006
723 LOCALISED INFECTION 14 0.0006
724 CARDIO-RESPIRATORY ARREST 24 0.0006
725 PALPITATIONS 67 0.0006
726 FATIGUE 445 0.0006
727 PRODUCTIVE COUGH 27 0.0006
728 CYST 7 0.0006
729 INFLAMMATION 29 0.0006
730 ISCHAEMIC STROKE 10 0.0006
731 RHINORRHOEA 36 0.0006
732 DECREASED APPETITE 129 0.0006
733 TREATMENT FAILURE 46 0.0006
734 BLOOD POTASSIUM INCREASED 9 0.0006
735 POLLAKIURIA 23 0.0006
736 PULMONARY THROMBOSIS 6 0.0005
737 LIVER FUNCTION TEST ABNORMAL 16 0.0005
738 OESOPHAGITIS 6 0.0005
739 METASTASES TO BONE 9 0.0005
740 PERIPHERAL SWELLING 84 0.0005
741 RENAL DISORDER 25 0.0005
742 NODULE 7 0.0005
743 THROAT IRRITATION 24 0.0005
744 FACE OEDEMA 9 0.0005
745 ORAL CANDIDIASIS 7 0.0005
746 ARTERIOSCLEROSIS 5 0.0005
747 DYSPNOEA EXERTIONAL 20 0.0005
748 HYPOAESTHESIA ORAL 8 0.0005
749 CIRCULATORY COLLAPSE 9 0.0005
750 SEIZURE 61 0.0005
751 GASTRIC HAEMORRHAGE 6 0.0005
752 DYSURIA 19 0.0005
753 VASCULITIS 6 0.0005
754 EOSINOPHILIA 9 0.0005
755 HAEMATEMESIS 13 0.0005
756 PERIPHERAL COLDNESS 7 0.0005
757 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
758 CONFUSIONAL STATE 82 0.0005
759 MENTAL STATUS CHANGES 14 0.0005
760 CEREBRAL HAEMORRHAGE 18 0.0005
761 OBESITY 8 0.0005
762 SCIATICA 8 0.0005
763 ABSCESS 8 0.0005
764 TOOTHACHE 9 0.0005
765 CORONARY ARTERY DISEASE 15 0.0005
766 BURSITIS 6 0.0005
767 PRESYNCOPE 12 0.0005
768 COGNITIVE DISORDER 23 0.0005
769 RASH PAPULAR 11 0.0005
770 EPILEPSY 15 0.0005
771 RIB FRACTURE 10 0.0005
772 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
773 FLUID OVERLOAD 7 0.0005
774 DRY EYE 24 0.0005
775 TINNITUS 22 0.0005
776 THERAPEUTIC RESPONSE DECREASED 29 0.0005
777 PRURITUS 183 0.0005
778 UNEVALUABLE EVENT 36 0.0005
779 LETHARGY 27 0.0005
780 NEOPLASM MALIGNANT 31 0.0005
781 DECREASED ACTIVITY 5 0.0005
782 EAR PAIN 9 0.0005
783 ORTHOSTATIC HYPOTENSION 8 0.0005
784 CHOLELITHIASIS 15 0.0005
785 EPISTAXIS 34 0.0005
786 DISORIENTATION 18 0.0005
787 CATARACT 27 0.0005
788 CEREBRAL INFARCTION 11 0.0004
789 NERVOUS SYSTEM DISORDER 14 0.0004
790 MYALGIA 76 0.0004
791 OROPHARYNGEAL PAIN 41 0.0004
792 MUSCULAR WEAKNESS 50 0.0004
793 SPEECH DISORDER 23 0.0004
794 WHEEZING 26 0.0004
795 LUNG NEOPLASM MALIGNANT 18 0.0004
796 CHOLECYSTECTOMY 5 0.0004
797 ILLNESS 45 0.0004
798 PRODUCT USE ISSUE 82 0.0004
799 CARDIOVASCULAR DISORDER 11 0.0004
800 DYSPHAGIA 41 0.0004
801 DEMENTIA 12 0.0004
802 PARAESTHESIA 67 0.0004
803 SKIN ULCER 11 0.0004
804 DYSARTHRIA 16 0.0004
805 INTESTINAL OBSTRUCTION 16 0.0004
806 MYOCARDIAL INFARCTION 74 0.0004
807 ADVERSE DRUG REACTION 38 0.0004
808 URINARY RETENTION 14 0.0004
809 LOWER LIMB FRACTURE 8 0.0004
810 TOXICITY TO VARIOUS AGENTS 70 0.0004
811 HEAD INJURY 13 0.0004
812 DISTURBANCE IN ATTENTION 22 0.0004
813 MUSCULOSKELETAL DISCOMFORT 7 0.0004
814 ORAL PAIN 9 0.0004
815 LACTIC ACIDOSIS 13 0.0004
816 ECZEMA 21 0.0004
817 MUSCULOSKELETAL PAIN 21 0.0004
818 RASH MACULAR 14 0.0004
819 SPINAL FRACTURE 8 0.0004
820 GASTROOESOPHAGEAL REFLUX DISEASE 32 0.0004
821 RASH ERYTHEMATOUS 19 0.0004
822 THROMBOSIS 31 0.0004
823 RESTLESS LEGS SYNDROME 7 0.0004
824 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 13 0.0004
825 HYPERSOMNIA 11 0.0004
826 MALAISE 168 0.0004
827 DEPRESSED LEVEL OF CONSCIOUSNESS 15 0.0004
828 SWELLING 35 0.0004
829 DIZZINESS 186 0.0004
830 HEPATIC CIRRHOSIS 7 0.0004
831 DRUG INEFFECTIVE 490 0.0004
832 POOR QUALITY SLEEP 8 0.0004
833 GASTRIC ULCER 7 0.0004
834 IMPAIRED HEALING 12 0.0004
835 MUSCLE SPASMS 67 0.0004
836 SUICIDE ATTEMPT 22 0.0004
837 ANGIOEDEMA 16 0.0004
838 CARDIAC FAILURE CONGESTIVE 29 0.0004
839 VERTIGO 22 0.0004
840 PROSTATE CANCER 29 0.0004
841 HAEMORRHOIDS 7 0.0004
842 ORAL HERPES 7 0.0004
843 HAEMOPTYSIS 10 0.0004
844 COORDINATION ABNORMAL 5 0.0004
845 KIDNEY INFECTION 7 0.0004
846 TYPE 2 DIABETES MELLITUS 12 0.0004
847 GASTRIC CANCER 9 0.0004
848 HEADACHE 220 0.0004
849 UNRESPONSIVE TO STIMULI 9 0.0003
850 PARANOIA 6 0.0003
851 ABDOMINAL DISTENSION 36 0.0003
852 HYPOTHYROIDISM 11 0.0003
853 AMENORRHOEA 6 0.0003
854 DYSPHONIA 20 0.0003
855 ARTHRALGIA 142 0.0003
856 HEAD DISCOMFORT 6 0.0003
857 DIABETES MELLITUS INADEQUATE CONTROL 6 0.0003
858 DYSPEPSIA 33 0.0003
859 ABDOMINAL PAIN UPPER 69 0.0003
860 OSTEONECROSIS 11 0.0003
861 CONTUSION 32 0.0003
862 RASH PRURITIC 18 0.0003
863 DEPRESSION 75 0.0003
864 NEURALGIA 8 0.0003
865 DISCOMFORT 20 0.0003
866 CEREBROVASCULAR ACCIDENT 55 0.0003
867 NASAL CONGESTION 19 0.0003
868 ABDOMINAL DISCOMFORT 54 0.0003
869 PRODUCT PRESCRIBING ISSUE 7 0.0003
870 AGGRESSION 16 0.0003
871 NASOPHARYNGITIS 58 0.0003
872 THERAPEUTIC PRODUCT EFFECT DECREASED 14 0.0003
873 ERECTILE DYSFUNCTION 8 0.0003
874 HERNIA 6 0.0003
875 CHROMATURIA 7 0.0003
876 HEART RATE IRREGULAR 7 0.0003
877 DRY MOUTH 25 0.0003
878 NEPHROLITHIASIS 14 0.0003
879 URTICARIA 51 0.0003
880 DIABETES MELLITUS 23 0.0003
881 FALL 99 0.0003
882 PRODUCT ADMINISTRATION ERROR 6 0.0003
883 FEEDING DISORDER 6 0.0003
884 MEDICATION ERROR 16 0.0003
885 HYPOAESTHESIA 43 0.0003
886 KNEE ARTHROPLASTY 6 0.0003
887 PAIN 174 0.0003
888 EATING DISORDER 6 0.0003
889 METABOLIC ACIDOSIS 9 0.0003
890 BLOOD CREATINE PHOSPHOKINASE INCREASED 8 0.0003
891 PAIN IN EXTREMITY 81 0.0003
892 HYPOGLYCAEMIA 13 0.0003
893 JOINT STIFFNESS 7 0.0003
894 FLATULENCE 15 0.0003
895 BLOOD URINE PRESENT 5 0.0003
896 GASTRIC DISORDER 9 0.0003
897 JAUNDICE 7 0.0003
898 DELIRIUM 9 0.0003
899 FREQUENT BOWEL MOVEMENTS 7 0.0003
900 LIMB DISCOMFORT 8 0.0003
901 LIMB INJURY 7 0.0003
902 JOINT SWELLING 31 0.0003
903 GAIT DISTURBANCE 49 0.0003
904 FLUID RETENTION 13 0.0003
905 ALOPECIA 50 0.0003
906 ARTHRITIS 20 0.0003
907 COMA 12 0.0003
908 DIABETIC KETOACIDOSIS 6 0.0002
909 SKIN EXFOLIATION 21 0.0002
910 COLITIS ULCERATIVE 11 0.0002
911 BLINDNESS 10 0.0002
912 AGITATION 18 0.0002
913 AGEUSIA 6 0.0002
914 GAIT INABILITY 8 0.0002
915 WEIGHT INCREASED 53 0.0002
916 HYPOACUSIS 10 0.0002
917 APHASIA 7 0.0002
918 PLASMA CELL MYELOMA 9 0.0002
919 SYSTEMIC LUPUS ERYTHEMATOSUS 8 0.0002
920 BALANCE DISORDER 19 0.0002
921 INFLUENZA LIKE ILLNESS 18 0.0002
922 MEMORY IMPAIRMENT 30 0.0002
923 AMNESIA 14 0.0002
924 ANXIETY 61 0.0002
925 EYE DISORDER 7 0.0002
926 HOT FLUSH 16 0.0002
927 EYE IRRITATION 12 0.0002
928 INSOMNIA 55 0.0002
929 URINARY INCONTINENCE 6 0.0002
930 FEELING ABNORMAL 47 0.0002
931 OSTEOPOROSIS 8 0.0002
932 CONDITION AGGRAVATED 59 0.0002
933 FEMUR FRACTURE 6 0.0002
934 BONE DENSITY DECREASED 6 0.0002
935 SOMNOLENCE 38 0.0002
936 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
937 MOVEMENT DISORDER 6 0.0002
938 BLADDER CANCER 11 0.0002
939 SWELLING FACE 12 0.0002
940 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
941 DERMATITIS ATOPIC 9 0.0002
942 DEPRESSED MOOD 9 0.0002
943 SLEEP DISORDER 12 0.0002
944 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
945 RESTLESSNESS 6 0.0002
946 CHRONIC KIDNEY DISEASE 12 0.0002
947 DRUG INTERACTION 24 0.0002
948 BLOOD CHOLESTEROL INCREASED 7 0.0002
949 BLOOD GLUCOSE INCREASED 28 0.0001
950 HAEMATOCHEZIA 8 0.0001
951 ROAD TRAFFIC ACCIDENT 6 0.0001
952 HOSPITALISATION 22 0.0001
953 RECTAL HAEMORRHAGE 6 0.0001
954 MOBILITY DECREASED 10 0.0001
955 VISUAL IMPAIRMENT 17 0.0001
956 DRY SKIN 18 0.0001
957 NERVOUSNESS 7 0.0001
958 HALLUCINATION 10 0.0001
959 VISION BLURRED 18 0.0001
960 TREATMENT NONCOMPLIANCE 7 0.0001
961 THERAPY INTERRUPTED 9 0.0001
962 SURGERY 7 0.0001
963 BREAST CANCER 11 0.0001
964 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 21 0.0001
965 INJECTION SITE REACTION 8 0.0001
966 BURNING SENSATION 8 0.0001
967 DYSGEUSIA 8 0.0001
968 BLISTER 6 0.0001
969 ASTHMA 12 0.0001
970 MIGRAINE 10 0.0001
971 COLORECTAL CANCER 5 0.0001
972 BLOOD GLUCOSE DECREASED 5 0.0001
973 INJECTION SITE BRUISING 8 0.0001
974 UNDERDOSE 7 0.0001
975 ARTHROPATHY 5 0.0001
976 SUICIDAL IDEATION 7 0.0001
977 ADVERSE EVENT 7 0.0001
978 FOETAL EXPOSURE DURING PREGNANCY 6 0.0001
979 MUSCULOSKELETAL STIFFNESS 6 0.0001
980 ACNE 5 0.0001
981 OVERDOSE 13 0.0001
982 PRODUCT QUALITY ISSUE 8 0.0001
983 INCORRECT DOSE ADMINISTERED 13 0.0001
984 PRODUCT DOSE OMISSION ISSUE 16 0.0001
985 PSORIASIS 7 0.0001
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000